Taysha Gene Therapies Inc share price logo

Taysha Gene Therapies Inc Share Price

NASDAQ: TSHA

Small Cap

$3.02

-0.05

(-1.79%)

as on

Taysha Gene Therapies Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.91
    $3.12
    downward going graph

    3.64%

    Downside

    3.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.05
    $3.4
    downward going graph

    65.23%

    Downside

    12.58%

    Upside

    downward going graph

Taysha Gene Therapies Inc share price movements today

Previous Close
$3.07
Open
$3.11
Volume
2.9M
Day's Low - High
$2.91 - $3.12
52 Week Low - High
$1.05 - $3.4

Taysha Gene Therapies Inc Historical Returns

1 Month Return
+ 4.42 %
3 Month Return
+ 20.87 %
1 Year Return
+ 34.06 %
3 Year Return
-1.29 %
5 Year Return
0 %

Taysha Gene Therapies Inc Stock Fundamentals & Key Indicators

Check Taysha Gene Therapies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$837.5M

EPS (TTM)

-0.322

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.85

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-88.0M

Revenue (TTM)

8.1M

Profit Margin

0.00%

Return On Equity TTM

139772900.00%

Taysha Gene Therapies Inc Stock Valuation

Track how Taysha Gene Therapies Inc P/E has moved over time to understand its valuation trends.

Taysha Gene Therapies Inc in the last 5 years

  • Overview

  • Trends

Lowest (3.33x)

September 30, 2024

Today (-3.85x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (15.33x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -3.85x

Taysha Gene Therapies Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Taysha Gene Therapies Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$837.5MNA-3.850.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Taysha Gene Therapies Inc Stock including INR - Dollar returns

The Taysha Gene Therapies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Taysha Gene Therapies Inc investment value today

Current value as on today

₹1,36,863

Returns

₹36,863

(+36.86%)

Returns from Taysha Gene Therapies Inc Stock

₹31,878 (+31.88%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Taysha Gene Therapies Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Taysha Gene Therapies Inc. Average target price of $8.67

Taysha Gene Therapies Inc Share Price Target

Get share price movements and forecasts by analysts on Taysha Gene Therapies Inc.

What analysts predicted

65.17%UPSIDE

Target Price

$8.67

Current Price

$3.02

Analyzed by

16 Analysts

Target

$8.67

Taysha Gene Therapies Inc target price $8.67, a slight upside of 65.17% compared to current price of $3.02. According to 16 analysts rating.

Taysha Gene Therapies Inc Stock's Interest Amongst Investors

Search interest for Taysha Gene Therapies Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Taysha Gene Therapies Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
4
2
4
3
3
1
1
2
2
1
Gross Profit
4
1
4
3
3
1
1
2
2
1
Operating Income
-16
-23
-16
-16
-24
-21
-25
-19
-21
-26
EBITDA
-15
-22
-115
48
-23
-20
-25
-18
-21
-26
Interest Expense
1
1
1
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-24
-117
47
-24
-20
-25
-18
-21
-26
Income Tax Expense
2
1
0
-3
0
-
-
0
-
-
Net Income
-20
-24
-117
47
-24
-20
-25
-18
-21
-26
Net Profit Margin
-426.24%
-1027.06%
-2467.07%
1324.67%
-705.39%
-1882.01%
-1427.52%
-929.03%
-935.23%
-1353.58%

Taysha Gene Therapies Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
2
15
8
Gross Profit
0
0
2
15
8
Operating Income
-43
-173
-162
-72
-91
EBITDA
-59
-172
-159
-105
-87
Interest Expense
0
1
3
4
0
Depreciation
0
0
1
1
1
Income Before Tax
-60
-174
-166
-111
-89
Income Tax Expense
-17
0
3
1
-89
Net Income
-43
-175
-166
-111
-89
Net Profit Margin
0.00%
0.00%
-6635.25%
-722.06%
-1071.62%

Taysha Gene Therapies Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-24
-117
47
-24
-20
-25
-18
-21
-26
Operating Cash Flow
-18
-17
-16
-19
-21
-21
-18
-22
-20
Investing Cash Flow
0
-3
0
0
0
0
0
0
0
Financing Cash Flow
0
140
-4
0
70
6
0
0
216
Change in Cash
-18
119
-20
-19
48
-15
-18
-22
196

Taysha Gene Therapies Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-60
-174
-166
-111
-89
Operating Cash Flow
-30
-117
-88
-73
-81
Investing Cash Flow
-9
-21
-24
-7
0
Financing Cash Flow
291
39
52
136
76
Change in Cash
251
-99
-61
56
-4

Global Institutional Holdings in Taysha Gene Therapies Inc

Funds
Holdings
venBio Select Advisor LLC
7.65%
RTW INVESTMENTS, LLC
7.18%
Morgan Stanley - Brokerage Accounts
6.44%
FMR Inc
5.98%
BlackRock Inc
5.2%

Insights on Taysha Gene Therapies Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 41.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 124.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TSHA stock has moved down by -5.2%

About Taysha Gene Therapies Inc

taysha gene therapies, inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. it primarily develops tsha-101 for the treatment of gm2 gangliosidosis; tsha-118 for the treatment of cln1 disease; tsha-102 for the treatment of rett syndrome; tsha-103 for the treatment of slc6a1 haploinsufficiency disorder; and tsha-104 for the treatment for surfeit locus 1 deficiency. the company also has strategic partnership with the university of texas southwestern medical center to develop and commercialize transformative gene therapy treatments. taysha gene therapies, inc. was founded in 2019 and is based in dallas, texas.
OrganisationTaysha Gene Therapies Inc
Headquarters3000 Pegasus Park Drive, Dallas, TX, United States, 75247
IndustryHealth Technology
CEOMr. Sean P. Nolan
E-voting on sharesClick here to vote

Key Management of Taysha Gene Therapies Inc

Name

Title

Mr. Kamran Alam CPA, M.B.A.

CFO & Corporate Secretary

Ms. Tracy M. Porter SPHR

Chief People Officer

Ms. Emily McGinnis M.P.H.

Chief Patient & External Affairs Officer

Mr. Frederick Porter Ph.D.

Chief of Staff & Technical Operations Officer

Mr. Sean McAuliffe

Chief Business Officer

Dr. Steven Gray Ph.D.

Chief Scientific Advisor of UT Southwestern Gene Therapy Program

Berge Minassian M.D.

Chief Medical Advisor of UT Southwestern Gene Therapy Program

Mr. Sean P. Nolan

CEO & Chairman

Dr. Sukumar Nagendran M.D.

President, Head of Research & Development and Director

Hayleigh Collins

Director of Corporate Communications & Investor Relations

FAQs

What is Taysha Gene Therapies Inc share price today?

Taysha Gene Therapies Inc share price today is $3.02 as on at the close of the market. Taysha Gene Therapies Inc share today touched a day high of $3.12 and a low of $2.91.

What is the 52 week high and 52 week low for Taysha Gene Therapies Inc share?

Taysha Gene Therapies Inc share touched a 52 week high of $3.4 on and a 52 week low of $1.05 on . Taysha Gene Therapies Inc stock price today i.e. is closed at $3.02,which is 11.18% down from its 52 week high and 187.62% up from its 52 week low.

What is Taysha Gene Therapies Inc's market capitalisation today?

Taysha Gene Therapies Inc market capitalisation is $0.00T as on .

How to invest in Taysha Gene Therapies Inc Stock (TSHA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Taysha Gene Therapies Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Taysha Gene Therapies Inc Shares that will get you 0.4967 shares as per Taysha Gene Therapies Inc share price of $3.02 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Taysha Gene Therapies Inc Stock (TSHA) from India?

Indian investors can start investing in Taysha Gene Therapies Inc (TSHA) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Taysha Gene Therapies Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Taysha Gene Therapies Inc share’s latest price of $3.02 as on September 16, 2025 at 1:29 am IST, you will get 3.3113 shares of Taysha Gene Therapies Inc. Learn more about fractional shares .